Cui ZL - Search Results

1

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer.

Aggarwal H, Han Y, Sheffield KM, Cui ZL. Aggarwal H, et al. Among authors: cui zl. J Comp Eff Res. 2023 Feb;12(2):e220143. doi: 10.2217/cer-2022-0143. Epub 2023 Jan 27. J Comp Eff Res. 2023. PMID: 36705061 Free PMC article.

2

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.

Paulson AS, Hess LM, Liepa AM, Cui ZL, Aguilar KM, Clark J, Schelman W. Paulson AS, et al. Among authors: cui zl. Gastric Cancer. 2018 Sep;21(5):831-844. doi: 10.1007/s10120-018-0796-z. Epub 2018 Feb 3. Gastric Cancer. 2018. PMID: 29397460

3

Application and comparison of generalized propensity score matching versus pairwise propensity score matching.

Cui ZL, Hess LM, Goodloe R, Faries D. Cui ZL, et al. J Comp Eff Res. 2018 Sep;7(9):923-934. doi: 10.2217/cer-2018-0030. Epub 2018 Jun 21. J Comp Eff Res. 2018. PMID: 29925271 Free article.

4

Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA.

Hess LM, Cui ZL, Mytelka DS, Han Y, Goodloe R, Schelman W. Hess LM, et al. Among authors: cui zl. Int J Colorectal Dis. 2019 Apr;34(4):581-588. doi: 10.1007/s00384-018-03227-5. Epub 2019 Jan 9. Int J Colorectal Dis. 2019. PMID: 30623219

5

Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practice.

Molife C, Hess LM, Cui ZL, Li XI, Beyrer J, Mahoui M, Oton AB. Molife C, et al. Among authors: cui zl. Future Oncol. 2019 Sep 1;15(25):2915-2931. doi: 10.2217/fon-2018-0876. Epub 2019 Feb 22. Future Oncol. 2019. PMID: 30793926 Free article.

6

Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States.

Hess LM, Cui ZL, Li XI, Molife C, Oton AB. Hess LM, et al. Among authors: cui zl. Curr Med Res Opin. 2021 Mar;37(3):469-476. doi: 10.1080/03007995.2020.1866516. Epub 2021 Feb 2. Curr Med Res Opin. 2021. PMID: 33337945

7

Defining treatment regimens and lines of therapy using real-world data in oncology.

Hess LM, Li X, Wu Y, Goodloe RJ, Cui ZL. Hess LM, et al. Among authors: cui zl. Future Oncol. 2021 May;17(15):1865-1877. doi: 10.2217/fon-2020-1041. Epub 2021 Feb 25. Future Oncol. 2021. PMID: 33629590

8

Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records.

Cui ZL, Kadziola Z, Lipkovich I, Faries DE, Sheffield KM, Carter GC. Cui ZL, et al. J Comp Eff Res. 2021 Jun;10(9):777-795. doi: 10.2217/cer-2020-0230. Epub 2021 May 13. J Comp Eff Res. 2021. PMID: 33980048 Free article.

9

Study of patient characteristics, treatment patterns, EGFR testing patterns and outcomes in real-world patients with EGFRm⁺ non-small cell lung cancer.

Winfree KB, Sheffield KM, Cui ZL, Sugihara T, Feliciano J. Winfree KB, et al. Among authors: cui zl. Curr Med Res Opin. 2022 Jan;38(1):91-99. doi: 10.1080/03007995.2021.1983530. Epub 2021 Oct 12. Curr Med Res Opin. 2022. PMID: 34544302

10

Generalizability of ORIENT-11 trial results to a US standard-of-care cohort with advanced non-small-cell lung cancer.

Nagasaka M, Molife C, Cui ZL, Stefaniak V, Li X, Kim S, Lee HY, Beyrer J, Blumenschein G. Nagasaka M, et al. Among authors: cui zl. Future Oncol. 2022 May;18(16):1963-1977. doi: 10.2217/fon-2022-0099. Epub 2022 Mar 31. Future Oncol. 2022. PMID: 35354280 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters